Advances in Hematology / 2020 / Article / Tab 2

Research Article

The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors

Table 2

Clinical and laboratory characteristics of the ET patients included in the study.

Patients characteristics

Number of patients233
Median follow-up (months)48.4 (range 0.3–313)
Median age at diagnosis (years)65.9 (range 14.5–92)
Age <60 years87 (37.3%)
Age >60 years146 (62.7%)
Female160 (68.7%)
Male73 (31.3%)
1 CVR92 (39.5%)
>1 CVR82 (35.2%)
JAK2 V617F positive/tested168/233 (72.1% of the total number of pts)
CALR mutated/tested21/65 (9% of the total number of pts)
MPL mutated/tested4/44 (1.7% of the total number of pts)
Triple negative40 (17.2% of the total number of pts)
Thrombosis before or at diagnosis48 (20.6%)
Thrombosis after diagnosis14 (6%)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.